MeVis Medical Solutions AG (M3V:GER)の戦略的SWOTと財務分析

Report Overview

Report Summary

MeVis Medical Solutions AG Strategic SWOT Analysis and Financial Insights – A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of MeVis Medical Solutions AG’s business operations. It provides a detailed analysis of the company’s financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company’s performance.

The report begins with in-depth information about MeVis Medical Solutions AG including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company’s key attributes.

Next, the report assesses MeVis Medical Solutions AG’s strategic standing through various analyses. The ESG spotlight evaluates the company’s environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company’s internal strengths and weaknesses, as well as external opportunities and threats. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of MeVis Medical Solutions AG’s overall strategic standing and supports informed decision-making and strategic planning.

The report also covers MeVis Medical Solutions AG’s financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares MeVis Medical Solutions AG’s financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors’ operations.

Finally, the report includes recent news and deal activities undertaken by MeVis Medical Solutions AG enhancing awareness of the company’s business trends, growth perspectives, and more.

Key Highlights

eVis Medical Solutions AG is a medical software company founded in 1997 in Bremen Germany. The company is headquartered at Caroline Herschel Strasse 1 in Bremen and operates as an expert provider of medical application software for image processing. MeVis focuses on innovative software and related services that support early detection and diagnosis in clinical practice. The company develops and markets software solutions for the analysis and evaluation of medical image data to medical device manufacturers and medical IT platform providers. Its clinical focus includes breast lung and liver cancer as well as neurological disorders supported across MRI digital mammography CT tomosynthesis and ultrasound imaging. MeVis supports industrial clients from initial product ideas through application development integration and ongoing quality assurance. The company also creates technical visualizations for education presentations and research and maintains close relationships with users worldwide while contributing to advances in radiology and medical imaging through long term expertise. It serves global customers and shares expertise through online academies seminars events and remote services reflecting its commitment to innovation quality collaboration and patient focused healthcare worldwide solutions

Scope

• Tactical Analysis:- Various strategic frameworks to gain insights into a MeVis Medical Solutions AG’s competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the MeVis Medical Solutions AG’s overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company’s future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
• Company Fundamentals:- These fundamentals offer valuable insights into the company’s history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the MeVis Medical Solutions AG’s main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

• Comprehensive Understanding of the MeVis Medical Solutions AG’s internal and external factors through SWOT analysis, Financial Analysis, and Competitors Benchmarking.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Additionally, available deep-dive analysis on the company MeVis Medical Solutions AG:

• MeVis Medical Solutions AG PESTLE Analysis
• MeVis Medical Solutions AG Value Chain Analysis
• MeVis Medical Solutions AG Porter’s Five Forces Analysis
• MeVis Medical Solutions AG VRIO Analysis
• MeVis Medical Solutions AG BCG Analysis
• MeVis Medical Solutions AG Segmentation, Targeting and Positioning (STP) Analysis
• MeVis Medical Solutions AG Ansoff Matrix Analysis

Table of Contents

Table of Contents 2
Tables 5
Charts 6
MeVis Medical Solutions AG – Key Company Facts 7
MeVis Medical Solutions AG – Company Description 8
MeVis Medical Solutions AG – Top Executives 9
MeVis Medical Solutions AG – Head Office & Locations 10
Head Office – Country 10
MeVis Medical Solutions AG – Products and Services 11
Products 11
Services 12
MeVis Medical Solutions AG – Corporate Strategy 13
MeVis Medical Solutions AG – Business Description 17
Development and Sale of Software Licenses 17
MeVis Medical Solutions AG – ESG Spotlight 19
Environment 19
Social 20
Corporate Governance 20
MeVis Medical Solutions AG – SWOT Analysis 22
Overview 22
Strengths 24
Weaknesses 26
Opportunities 28
Threats 30
MeVis Medical Solutions AG – Financial Deep Dive 32
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 32
Profit and Loss Statement 34
Summary of Profit and Loss Statement 34
Balance Sheet 38
Summary of Balance Sheet 38
Cash Flow Statement 42
Summary of Cash Flow Statement 42
Key Financial Ratio Analysis 46
MeVis Medical Solutions AG – Ratio Charts 48
Activity Ratio Charts 48
Growth Ratios Charts 49
Leverage Ratio Charts 53
Liquidity Ratio Charts 55
Profitability Ratio Charts 57
Competing Players 59
Sectra AB 60
Key Company Facts 60
Company Description 60
Key Financials 61
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 61
Key Financial Ratio Analysis 66
Key Financials 68
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 68
Key Financial Ratio Analysis 73
Median Technologies SA 75
Key Company Facts 75
Company Description 75
Key Financials 76
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 76
Key Financial Ratio Analysis 81
Appendix 83
Definitions 83
SWOT Analysis 83
PESTLE Analysis 83
Value Chain Analysis 83
ESG Spotlight 83
Financial Deep Dive 83
Financial Ratios 84
Activity Ratios 84
Growth Ratios 86
Leverage Ratios 89
Liquidity Ratios 91
Market Ratios 93
Profitability Ratios 95
Research Methodology 97
Disclaimer 98
Contact Us 98

List of Tables

Table 1: MeVis Medical Solutions AG – Company Facts 7
Table 2: MeVis Medical Solutions AG – Digital Presence 7
Table 3: MeVis Medical Solutions AG – Top Executives 9
Table 4: MeVis Medical Solutions AG – Products 11
Table 5: MeVis Medical Solutions AG – Services 12
Table 6: MeVis Medical Solutions AG – Share Price Trend – Jun-2025 to Jun-2026 32
Table 7: MeVis Medical Solutions AG – Profit and Loss Statement – 2022-2025 35
Table 8: MeVis Medical Solutions AG – Balance Sheet – 2022-2025 39
Table 9: MeVis Medical Solutions AG – Cash Flow Statement – 2022-2025 43
Table 10: MeVis Medical Solutions AG – Ratio Analysis – 2022-2025 46
Table 11: MeVis Medical Solutions AG – Competing Players 59
Table 13: Competing Players – Sectra AB – Key Company Facts 60
Table 14: Sectra AB – Share Price Trend – Jun-2025 to Jun-2026 61
Table 15: Competing Players – Sectra AB – Profit and Loss Statement – 2021-2024 63
Table 16: Sectra AB – Balance Sheet 2021-2024 64
Table 17: Sectra AB – Cash Flow Statement 2021-2024 65
Table 18: Sectra AB – Ratio Analysis – 2021-2024 66
Table 21: Intrasense SA – Share Price Trend – Jun-2025 to Jun-2026 68
Table 22: Competing Players – Intrasense SA – Profit and Loss Statement – 2022-2025 70
Table 23: Intrasense SA – Balance Sheet 2022-2025 71
Table 24: Intrasense SA – Cash Flow Statement 2021-2024 72
Table 25: Intrasense SA – Ratio Analysis – 2022-2025 73
Table 26: Competing Players – Median Technologies SA – Key Company Facts 75
Table 27: Median Technologies SA – Share Price Trend – Jun-2025 to Jun-2026 76
Table 28: Competing Players – Median Technologies SA – Profit and Loss Statement – 2022-2025 78
Table 29: Median Technologies SA – Balance Sheet 2022-2025 79
Table 30: Median Technologies SA – Cash Flow Statement 2022-2025 80
Table 31: Median Technologies SA – Ratio Analysis – 2022-2025 81

List of Figures

Figure 1: MeVis Medical Solutions AG – SWOT Analysis 23
Figure 2: MeVis Medical Solutions AG – Average Share Price Trend – Jun-2025 to Jun-2026 33
Figure 3: MeVis Medical Solutions AG – Profit and Loss Statement – 2022-2025 37
Figure 4: MeVis Medical Solutions AG – Balance Sheet – 2022-2025 41
Figure 5: MeVis Medical Solutions AG – Cash Flow Statement 2022-2025 45
Figure 6: MeVis Medical Solutions AG – Activity Ratio Charts 48
Figure 7: MeVis Medical Solutions AG – Growth Ratio Charts (Value %) 49
Figure 8: MeVis Medical Solutions AG – Leverage Ratio Charts 53
Figure 9: MeVis Medical Solutions AG – Liquidity Ratio Charts 55
Figure 10: MeVis Medical Solutions AG – Profitability Ratio Charts (Value %) 57
Figure 11: Sectra AB – Average Share Price Trend – Jun-2025 to Jun-2026 62
Figure 12: Sectra AB – Profit and Loss Statement – 2021-2024 63
Figure 13: Sectra AB – Balance Sheet – 2021-2024 64
Figure 14: Sectra AB – Cash Flow Statement 2021-2024 65
Figure 15: Intrasense SA – Average Share Price Trend – Jun-2025 to Jun-2026 69
Figure 16: Intrasense SA – Profit and Loss Statement – 2022-2025 70
Figure 17: Intrasense SA – Balance Sheet – 2022-2025 71
Figure 18: Intrasense SA – Cash Flow Statement 2021-2024 72
Figure 19: Median Technologies SA – Average Share Price Trend – Jun-2025 to Jun-2026 77
Figure 20: Median Technologies SA – Profit and Loss Statement – 2022-2025 78
Figure 21: Median Technologies SA – Balance Sheet – 2022-2025 79
Figure 22: Median Technologies SA – Cash Flow Statement 2022-2025 80